期刊文献+

抗阿尔茨海默病药物研究进展 被引量:4

Research progress of anti-Alzheimer’s Disease drugs
下载PDF
导出
摘要 阿尔茨海默病是一种神经退行性认知功能障碍,表现为记忆力、判断力、抽象思维能力的丧失,并逐步导致身体机能丧失,最终引发死亡。阿尔茨海默病的病因及发病机制目前尚不明确,普遍认为存在多种假说,诸如胆碱能神经元假说、β淀粉样蛋白假说、Tau蛋白缠结假说等。概述了抗老年痴呆药的发展现状,阿尔茨海默病可能的病理机制,详细介绍了有关天然产物在预防及治疗阿尔兹海默症的进展。 Alzheimer’s Disease is a neurodegenerative cognitive disorder characterized by the loss of memory, judgment, abstract thinking, and gradually leads to loss of body function and ultimately death. The etiology and pathogenesis of Alzheimer’s Disease are still unclear. It is generally believed that there are many hypotheses, such as cholinergic neuron hypothesis,β-amyloid protein hypothesis, Tau protein entanglement hypothesis and so on. The present situation of anti-dementia drugs, the possible pathological mechanism of Alzheimer’s Disease and the progress of natural products in the prevention and treatment of Alzheimer’s Disease were reviewed in this paper.
作者 孙紫彤 马盼 陈华飞 诸许慧 傅志贤 Sun Zitong;Ma Pan;Chen Huafei;Zhu Xuhui;Fu Zhixian(Southeast University Chengxian College, Nanjing 210088, China)
出处 《现代盐化工》 2019年第2期45-46,共2页 Modern Salt and Chemical Industry
基金 江苏省大学生实践创新计划(SCX1814)
关键词 阿尔茨海默病 发病机制 天然产物 Alzheimer's Disease pathogenesis natural products
  • 相关文献

参考文献2

二级参考文献16

  • 1赵琳,魏敏杰,金万宝.维生素E在阿尔茨海默病防治中的研究进展[J].国外医学(老年医学分册),2005,26(5):202-205. 被引量:4
  • 2刘英华,王建枝.tau蛋白异常与阿尔茨海默病的关系[J].生命的化学,2006,26(2):108-110. 被引量:8
  • 3王杉,蒋宁,周文霞,张永祥.阿尔茨海默病防治药物靶标的研究进展[J].中国新药杂志,2007,16(11):831-836. 被引量:9
  • 4McKeage K. Spotlight on memantine in moderate to severe Alzheimer's disease[ J. Drugs & Aging,2010, 27(2) : 177 - 179.
  • 5Carrasco MM, Aguera L, Gil P, et al. Safety and effectiveness of done- pezil on behavioral symptoms in patients with Alzheimer disease [ J ]. Alzheimer Disease & Associated Disorders,2011, 25 (4) : 333 - 340.
  • 6Fujii A, Shinagawa R, Chatani Y, et al. Pharmacological profile and clinical results of the rivastigmine patch as a new therapeutic agent for Alzheimer's disease [ J ]. Folia Pharmacologica Japonica, 2012, 139 (1) : 26 -32.
  • 7Saint- Aubert L, Planton M, Hannequin D, et al. Amyloid imaging with AV45 ( 18F - fiorbetapir) in a cognitively normal AbetaPP dupli- cation carrier[ J ]. Journal of Alzheimer' s disease : JAD, 2012, 28 (4): 877-883.
  • 8Imbimbo BP, Ottonello S, Frisardi V, et al. Solanezumab for the treatment of mild - to - moderate Alzheimer's disease[ J]. Expert Re- view of Clinical Immunology,2012, 8(2) : 135 - 149.
  • 9Panza F, Frisardi V, lmbimbo BP, et al. Anti - beta - arnyloid irnmu- notherapy for Alzheimer's disease: focus on bapineuzumab [ J ]. Cur- rent Alzheimer Research,2011, 8(8) : 808 -817.
  • 10Seo JS, Baek IS, Leem YH, et al. SK - PC - B70M alleviates neuro- logic symptoms in G93A - SOD1 amyotrophic lateral sclerosis mice [ J]. Brain Research ,2011, 1368 : 299 - 307.

共引文献6

同被引文献54

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部